Search Results - "SENTZ, D. L"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats by EGORIN, M. J, YUAN, Z.-M, SENTZ, D. L, PLAISANCE, K, EISEMAN, J. L

    “…To define the plasma concentrations of butyrate achieved and the profile of plasma butyrate concentrations versus time in mice and rats treated with tributyrin…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I by SHARKEY, E. M, O'NEILL, H. B, KAVARANA, M. J, HAIBO WANG, CREIGHTON, D. J, SENTZ, D. L, EISEMAN, J. L

    “…The enediol analogue S-(N-p-chlorophenyl-N-hydroxycarbamoyl)glutathione (CHG) is a powerful, mechanism-based, competitive inhibitor of the…”
    Get full text
    Journal Article
  3. 3

    Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice by EISEMAN, J. L, EDDINGTON, N. D, LESLIE, J, MACAULEY, C, SENTZ, D. L, ZUHOWSKI, M, KUJAWA, J. M, YOUNG, D, EGORIN, M. J

    “…We defined the pharmacokinetics of paclitaxel after i.v., i.p., p.o., and s.c. administration of 22.5 mg/kg to CD2F1 mice. Additional mice were studied after…”
    Get full text
    Journal Article
  4. 4

    Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer by EISEMAN, J. L, ROGERS, F. A, YANPING GUO, KAUFFMAN, J, SENTZ, D. L, KLINGER, M. F, CALLERY, P. S, KYPRIANOU, N

    Published in Cancer research (Chicago, Ill.) (01-11-1998)
    “…Interference with polyamine transport and biosynthesis has emerged as an important anticancer strategy involving polyamine analogues and specific inhibitors of…”
    Get full text
    Journal Article
  5. 5

    Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent by EGORIN, M. J, ZUHOWSKI, E. G, SENTZ, D. L, DOBSON, J. M, CALLERY, P. S, EISEMAN, J. L

    “…Pc4 is a silicone phthalocyanine photosensitizing agent that is entering clinical trials. Studies were undertaken in mice to develop a suitable formulation and…”
    Get full text
    Journal Article
  6. 6

    Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice by CONLEY, B. A, RAMSLAND, T. S, SENTZ, D. L, SUHLAN WU, ROSEN, D. M, WOLLMAN, M, EISEMAN, J. L

    “…The efficacy of 13-cis-retinoic acid (13-CRA) given as a single agent or in combination with tamoxifen (TAM) was determined in athymic nude mice bearing…”
    Get full text
    Journal Article
  7. 7

    Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1 by EGORIN, Merrill J, ZUHOWSKI, Eleanor G, ROSEN, D. Marc, SENTZ, Dorothy L, COVEY, Joseph M, EISEMAN, Julie L

    Published in Cancer chemotherapy and pharmacology (01-04-2001)
    “…17-(Allylamino)-17-demethoxygeldanamycin (17AAG) is a benzoquinone ansamycin compound agent that has entered clinical trials. Studies were performed in mice…”
    Get full text
    Journal Article
  8. 8

    Synthesis and Antitumor Evaluation of a Highly Potent Cytotoxic DNA Cross-Linking Polyamine Analogue, 1,12-Diaziridinyl-4,9-diazadodecane by Li, Yanlong, Eiseman, Julie L, Sentz, Dorothy L, Rogers, Faye A, Pan, Su-Shu, Hu, Li-Tai, Egorin, Merrill J, Callery, Patrick S

    Published in Journal of medicinal chemistry (05-01-1996)
    “…A diaziridinylspermine analogue, 1,12-diaziridinyl-4,9-diazadodecane (NSC-667005), was synthesized as a bisalkylating agent with a polyamine backbone. DNA…”
    Get full text
    Journal Article
  9. 9

    In vitro metabolism by mouse and human liver preparations of halomon, an antitumor halogenated monoterpene by EGORIN, M. J, ROSEN, D. M, BENJAMIN, S. E, CALLERY, P. S, SENTZ, D. L, EISEMAN, J. L

    “…To characterize the enzymes responsible for and metabolites produced from the metabolism of halomon, a halogenated monoterpene that is isolated from the red…”
    Get full text
    Journal Article
  10. 10

    Plasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, and antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii by EGORIN, M. J, SENTZ, D. L, ROSEN, D. M, BALLESTEROS, M. F, KEARNS, C. M, CALLERY, P. S, EISEMAN, J. L

    “…The purpose of the present study was to define the plasma pharmacokinetics, bioavailability, and tissue distribution in mice of halomon, a halogenated…”
    Get full text
    Journal Article
  11. 11

    Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice by EISEMAN, J. L, YUAN, Z.-M, EDDINGTON, N. D, SENTZ, D. L, CALLERY, P. S, EGORIN, M. J

    “…The pharmacokinetics of 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane (BE-4-4-4-4) were determined in CD2F1 female mice after administration of i.v. bolus…”
    Get full text
    Journal Article